Tebubio Banner General Newsletter

Summer has officially arrived, and with it, soaring temperatures, the faint smell of sun cream in the corridors, and the unmistakable sound of out-of-office autoreplies piling up in inboxes across the continent.

Before you trade your lab coat for a beach towel, the Tebubio team wanted to take a moment to share our latest news, updates, and highlights. Consider it light reading, best enjoyed with a cold beverage and absolutely no obligation to take notes.

Don't Miss A Pancreatic Islets Lot

Get Priority Access to Fresh Human Pancreatic Islets 

Join our dedicated notification list to receive real-time alerts as soon as new Islets lots, from our supplier Prodo Labs, become available, including essential donor details, purity, viability, and shipping schedules.

Availability is limited and offered on a first-come, first-served basis.

Sign up for real-time islet availability alerts ➔

Product Highlights

Cleaner IVT, better mRNA with TriLink

Discover how CleanScribe™ RNA Polymerase reduces dsRNA formation by up to 85% during in vitro transcription, without compromising mRNA yield, integrity, or capping efficiency.

Read more ➔

Visualise lipid droplets with confidence

Explore reliable solutions for high-contrast imaging of intracellular lipid accumulation, designed to overcome the limitations of conventional staining methods.

Read more ➔

Find the right assay for your HA research (reduced prices)

Compare three optimised hyaluronic acid assays and select the best fit for your sample type, sensitivity needs, and workflow. Now available with 15% off selected products.

Read more ➔

First centriole & cilia-selective probe

Discover CenSpark650, a first-in-class cell-permeable small-molecule probe engineered to selectively label centriolar and axonemal microtubules in live and fixed specimens across species.

Read more ➔

Save 15% on the CUTANATM CUT&TAG Kit    

Profile histone PTMs with an all-inclusive, streamlined workflow delivering superior sensitivity, lower sequencing costs, and reliable results, from cells to sequencing libraries in a single tube.

Read more ➔

Fully animal-free growth factor

ISOKINE® PDGF-BB is a plant-based recombinant human growth factor delivering high biological activity, endotoxin-free purity, and reproducible results for MSC expansion, fibroblast proliferation, etc.

Read more ➔

Tebubio's CRO Services

With dedicated PhD-level project management and tailored solutions, we help researchers move faster from discovery to preclinical development

What if your CRO could support every stage of your research project?

At Tebubio, our integrated expertise spans 4 key platforms:

  • RNA-Based Therapeutic Discovery

  • In Vitro Modelling

  • Biomarker Mapping

  • Data Analysis

Learn more about our CRO capabilities

On-Demand Webinar

Unlocking the power of immuno-oncology

Explore cutting-edge tools and strategies for cancer research, covering immune checkpoint targets; PD-1/PD-L1, LAG-3, TIGIT, VISTA; combination immunotherapy approaches, and CAR-T workflows.

Our experts walk you through the latest translational research solutions to accelerate your immuno-oncology programmes, from target validation to functional assays.

Watch the webinar

Monthly Highlights

Double ISO certification: audit passed with zero non-conformities

Tebubio has successfully completed its annual ISO surveillance audit, with both ISO 9001 (Quality Management) and ISO 14001 (Environmental Management) certifications confirmed. 

Auditors concluded that "the quality management system is fully efficient", a testament to over 20 and 10 years of certified excellence, respectively.

Learn more about our capabilities ➔

Highlights Brochure: fueling scientific breakthroughs

As we enter the summer season, we are pleased to unveil our latest "Highlights" edition.

Designed to inspire and support your research, this Spring/Summer 2026 edition brings together innovative products, expert services, and efficient procurement solutions.

Download the brochure ➔

Stay Ahead in Your Research

Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in key research areas.